Strategic Advisors LLC Purchases New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Strategic Advisors LLC acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 427 shares of the biotechnology company's stock, valued at approximately $254,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Bleakley Financial Group LLC increased its position in Axon Enterprise by 7.9% in the third quarter. Bleakley Financial Group LLC now owns 1,507 shares of the biotechnology company's stock worth $602,000 after buying an additional 110 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Axon Enterprise by 2.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 7,391 shares of the biotechnology company's stock valued at $2,953,000 after purchasing an additional 143 shares during the last quarter. Stratos Wealth Advisors LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at about $259,000. Blue Trust Inc. lifted its position in Axon Enterprise by 234.5% in the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company's stock valued at $116,000 after purchasing an additional 204 shares during the last quarter. Finally, Commonwealth Equity Services LLC lifted its position in Axon Enterprise by 7.5% in the 3rd quarter. Commonwealth Equity Services LLC now owns 75,201 shares of the biotechnology company's stock valued at $30,050,000 after purchasing an additional 5,218 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research report on Friday, November 8th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "hold" rating and set a $625.00 price objective on the stock. in a research report on Thursday. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday. Finally, TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $561.31.

Remove Ads

Axon Enterprise Stock Down 5.3 %

Shares of AXON traded down $28.59 during trading hours on Friday, hitting $513.22. 1,453,359 shares of the company were exchanged, compared to its average volume of 719,192. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $39.13 billion, a PE ratio of 132.62, a PEG ratio of 5.95 and a beta of 1.05. The firm's 50 day moving average is $619.94 and its 200-day moving average is $517.11. Axon Enterprise, Inc. has a 52 week low of $265.32 and a 52 week high of $715.99.

Insider Buying and Selling

In related news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.